Welcome to CDERLearn, the web page for educational tutorials offered by the Center for Drug Evaluation and Research (CDER). CDER's primary mission is to make certain that safe and effective drugs are available to the American people. There is, however, a strategic initiative to inform and educate people about the safe use of medicine, the drug regulatory process, the vital role health care professionals play to assist FDA in fulfilling its duties, and many other important issues. Online training is one way to share FDA expertise with many more people than face-to-face classroom sessions would allow, and we will offer additional CDERLearn courses in the future.
FDA’s Role in Public Health: Drug Efficacy, Safety, Quality, and Beyond
The purpose of this continuing education (CE) course is to educate a national audience of health care providers, industry, and consumers about the basics of the FDA drug regulatory process and the science that supports CDER’s mission. The course will also educate the nation’s health care providers about their role in communicating drug information to their patients. This updated CDERLearn course replaces the former CDERLearn course, "The Past, Present, and Future of Human Drug Regulation."
FDA Overview of Biosimilar Products
This continuing education (CE) course provides an understanding of biological products and biosimilar products and a description of FDA’s general approach to the development and approval of biosimilar products. The target audience for this course is healthcare professionals, including physicians, physician assistants, nurses, nurse practitioners, and pharmacists.
CDER Small Business and Industry Education Series
CDER's Small Business and Industry Assistance Program has developed a series of Web-based courses to educate regulated small pharmaceutical industry.
Case Studies in FDA's Drug Regulatory Processes
For patients and patient advocacy groups, health professionals, small business, and pharmaceutical and clinical innovators designed to advance knowledge of drug regulatory processes. Each case study promotes active learning through exercises, instructor-led discussions, and quizzes.
A series of educational modules based on The CDER Forum for International Regulatory Authorities Lectures. The modules present an overview of the work of the Center for Drug Evaluation and Research.
The FDA Bad Ad Program and Prescription Drug Promotion
This continuing education (CE) Web education course is designed to raise awareness among health care professionals (HCPs) about prescription drug promotion that may be misleading and educates HCPs about how to easily report these problems to FDA's Office of Prescription Drug Promotion.
Medicines in My Home -An Interactive Home
This educational program is designed to help consumers from adolescence to adulthood understand and use the Drug Facts label to choose over-the-counter medicines and use them safely.
- FDA Medwatch and Patient Safety
An online tutorial covering the MedWatch program goals of broadcasting safety information and encouraging adverse event reporting
- Field Investigators: Adverse Drug Effects (ADE) Investigators (2000)
- The FDA Process for Approving Generic Drugs
Credit is no longer available for this course.
- An Introduction to the Improved FDA Prescription Drug Labeling
Credit is no longer available for this course. The primary audience for this course content is physicians, physician assistants, pharmacists, nurses, nurse practitioners, and dentists. Secondary audiences include other health practitioners who are interested in the revised prescription drug labeling.